Tampa General Hospital Named One of Newsweek’s Best Smart Hospitals for 2024

The academic health system is recognized for its pioneering use of technology, including artificial intelligence and digital innovation.

Summation

  • Both GE and Palantir have been instrumental in the development and execution of Tampa General’s early warning system for the prevention and treatment of sepsis, a potentially life-threatening response to an infection in the body that can move with lightning speed.
  • As a result of this effort, the academic health system has seen a dramatic reduction in mortality from sepsis in patients admitted to the hospital.
  • “The latest technologies taking the health care industry by storm — whether artificial intelligence, predictive analytics, telehealth, or something else — are the future of how we can better support our team members and deliver the best care possible to our community.

Tampa General Hospital (TGH) has been recognized as one of the World’s Best Smart Hospitals for 2024 by Newsweek and Statista. This prestigious global accolade is a testament to Tampa General’s commitment to harnessing cutting-edge technology to enable world-class patient care, improve care coordination and streamline hospital operations.

“As a leading academic health system, driving innovation is essential to our commitment to providing world-class care,” said John Couris, president and CEO of Tampa General Hospital. “This recognition demonstrates our team’s focus on adopting forward-thinking advancements in technology to maximize new approaches. The end result is better treatments and outcomes for patients now and long into future.”

The World’s Best Smart Hospitals 2024 rankings showcase the top 330 hospitals globally that are at the forefront of smart health care technologies. This recognition is the result of a comprehensive evaluation process that encompassed recommendations from more than 2,000 hospital managers and medical professionals across 28 countries. Hospitals were assessed in five key sub-categories:

Electronic functionalities
Telemedicine
Digital imaging
Artificial intelligence
Robotics

Tampa General’s journey to world-class care is guided by its vision of technology as a crucial element in delivering excellence. In the past year, the academic health system has implemented predictive analytics and artificial intelligence.

One standout example of Tampa General’s success in this realm is its partnership with GE Healthcare and the utilization of the CareComm command center. Similar to air traffic control, CareComm functions as a command center for patient care consistently gathering thousands of data points to provide insights, identify trends and drive decisions.

In 2022, Tampa General partnered with Palantir, a leading analytics platform to employ artificial intelligence (AI) capabilities to augment critical decision-making on the front lines. Both GE and Palantir have been instrumental in the development and execution of Tampa General’s early warning system for the prevention and treatment of sepsis, a potentially life-threatening response to an infection in the body that can move with lightning speed.

Clinical data was aggregated to predict the onset of sepsis and prioritize the activation of a rapid-response team intervention. The predictive analytics algorithm monitors real-time information from Tampa General’s electronic health record (EHR) and uses weighted rules-based logic to flag patients at high risk for sepsis.

As a result of this effort, the academic health system has seen a dramatic reduction in mortality from sepsis in patients admitted to the hospital. The mortality rate due to sepsis was reduced by 3% — which accounts for close to 200 lives saved since implementation.

“We’re honored to have earned a place among Newsweek’s World’s Best Smart Hospitals 2024. I attribute this recognition to the continuous innovation driven by our team,” said Scott Arnold, executive vice president and chief information officer at Tampa General Hospital. “The latest technologies taking the health care industry by storm — whether artificial intelligence, predictive analytics, telehealth, or something else — are the future of how we can better support our team members and deliver the best care possible to our community.”

For more information about the World’s Best Smart Hospitals 2024 rankings, please visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

- Advertisement -

spot_img

- Advertisement -

New Inflammatory Bowel Disease Center Opens at Northwell Health

The new Inflammatory Bowel Disease Center, located at 125 Community Drive in Manhasset, has 13 exam rooms, two procedural rooms and six infusion bays. Since it started operations, people have travelled from all over the country – and as far away as Alaska – to receive high-quality care.

Cold Spring Harbor Laboratory and Northwell Health Extend Strategic Affiliation

“The alliance between Cold Spring Harbor Laboratory (CSHL) and Northwell Health brings transformative bioscience research into the clinic,” says CSHL President & CEO Bruce Stillman. “As New York’s largest healthcare provider, Northwell Health serves a remarkably diverse patient population. This agreement will provide patient communities with greater access to cutting-edge biomedical technology, allowing for more precise diagnoses and treatments, and ultimately facilitating new breakthroughs in cancer care.”

Hackensack Meridian Neuroscience Institute at JFK University Medical Center Receives $2.2 Million Research Grant to Study A Novel Traumatic Brain Injury Treatment

The NIH grant will fund a project entitled “Neutrophil Extracellular Traps And Associated Pathogenesis In TBI: A Novel Peptide Therapeutic Strategy” proposed by Mohammed Abdul Muneer, MSc, PhD, Research Scientist & Principal Investigator, Hackensack Meridian Neuroscience Institute at JFK University Medical Center, and Associate Professor of Neurology at the Hackensack Meridian School of Medicine.

By using this website you agree to accept Medical Device News Magazine Privacy Policy